HP-4

N/A

Report date: 2024/12/03 14:06:30
NME

Base Information

Drug NameHP-4
Drug Alias NameChorionic gonadotropinBTL-cghuman chorionic gonadotropinLDI-100ML-04A +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHuman chorionic gonadotropin ligand
TargetsHuman chorionic gonadotropin
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMilkhaus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMilkhaus Laboratory Inc
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A